Mycobacterium fortuitum infection of the hip joint: a case report and literature review

Osteoarticular infections caused by Mycobacterium fortuitum are exceedingly rare and often result in delayed diagnosis due to nonspecific clinical manifestations. We report a case of septic arthritis of the hip in a 47-year-old man, in which M. fortuitum was identified from synovial fluid by 16S rRNA gene sequencing (99% identity to GenBank reference sequence CP011269.1). Upon definitive diagnosis, antimicrobial therapy was adjusted to intravenous azithromycin and levofloxacin combined with oral trimethoprim-sulfamethoxazole (TMP-SMX). Following clinical improvement, treatment was transitioned to oral azithromycin, levofloxacin, and TMP-SMX for 12 months. At the 18-month follow-up, the patient remained in complete remission without recurrence. This case highlights the critical role of 16S rRNA sequencing in diagnosing non-tuberculous mycobacterial infections and informs therapeutic strategies for similar rare infections.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-03-23
DOI
https://doi.org/10.3389/fimmu.2026.1762789
Primary Topic
Mycobacterium research and diagnosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mycobacterium fortuitum infection of the hip joint: a case report and literature review

Weili Gao, Cuiying Zheng, Xiaofeng Zhang, Mei Song et al.
Frontiers in Immunology
Mycobacterium research and diagnosis
article

Mycobacterium fortuitum infection of the hip joint: a case report and literature review

Weili Gao, Cuiying Zheng, Xiaofeng Zhang, Mei Song, Jiahao Hao, Lijie Zhang, Shufang Liu, Yumei Guo, Wei Zhang, Yiran Zhao, Kun Shan, Hong Zhang
article en

Abstract

Osteoarticular infections caused by Mycobacterium fortuitum are exceedingly rare and often result in delayed diagnosis due to nonspecific clinical manifestations. We report a case of septic arthritis of the hip in a 47-year-old man, in which M. fortuitum was identified from synovial fluid by 16S rRNA gene sequencing (99% identity to GenBank reference sequence CP011269.1). Upon definitive diagnosis, antimicrobial therapy was adjusted to intravenous azithromycin and levofloxacin combined with oral trimethoprim-sulfamethoxazole (TMP-SMX). Following clinical improvement, treatment was transitioned to oral azithromycin, levofloxacin, and TMP-SMX for 12 months. At the 18-month follow-up, the patient remained in complete remission without recurrence. This case highlights the critical role of 16S rRNA sequencing in diagnosing non-tuberculous mycobacterial infections and informs therapeutic strategies for similar rare infections.

Frontiers in ImmunologyVol. 17
Hebei Medical University (CN), Nantong University (CN), Third Hospital of Hebei Medical University (CN), Yancheng First People's Hospital (CN), Hebei Provincial Center for Disease Control and Prevention (CN), Baoding People's Hospital (CN)
Good health and well-being
Openalex Percentile: Top 14%
Mycobacterium research and diagnosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Mycobacterium fortuitum infection of the hip joint: a case report and literature review — Weili Gao, Cuiying Zheng, et al. · Frontiers in Immunology (2026) | TGRS Research Map | TGRS